Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (501-510 of 1,026) with videos related to

Pageof 103
Sort By:
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
The American Journal of Cardiology|January 8, 2017
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective CohortConnor A Emdin, Amit V Khera, Pradeep Natarajan, et al.
Cell Metabolism|August 2, 2005
Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalphaMichael Lehrke, Corinna Lebherz, Segan C Millington, et al.
Clinical and Translational Science|February 20, 2010
Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterolFrançois Briand, Snehal U Naik, Ilia Fuki, et al.
Circulation Research|January 17, 2015
Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosisKevin M Patel, Alanna Strong, Junichiro Tohyama, et al.
Journal of Lipid Research|May 11, 1992
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosisD J Rader, R E Gregg, M S Meng, et al.
Coronary Artery Disease|March 17, 2004
Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemiaDonald B Hunninghake, Evan A Stein, Harold E Bays, et al.
Pharmacogenetics and Genomics|June 20, 2017
Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapySony Tuteja, Lu Wang, Richard L Dunbar, et al.
Lipids|April 30, 2014
Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid speciesYanbo Yang, Takashi Kuwano, William R Lagor, et al.
European Heart Journal|January 14, 2016
Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 studyJohn J P Kastelein, Steven E Nissen, Daniel J Rader, et al.
Pageof 103

Showing results (501-510 of 1,026) with videos related to

Sort By:
Pageof 103
Clinical and Translational Science|August 11, 2017
Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled TrialRichard L Dunbar, Rajesh Movva, LeAnne T Bloedon, et al.
The American Journal of Cardiology|January 8, 2017
Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective CohortConnor A Emdin, Amit V Khera, Pradeep Natarajan, et al.
Cell Metabolism|August 2, 2005
Diet-dependent cardiovascular lipid metabolism controlled by hepatic LXRalphaMichael Lehrke, Corinna Lebherz, Segan C Millington, et al.
Clinical and Translational Science|February 20, 2010
Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterolFrançois Briand, Snehal U Naik, Ilia Fuki, et al.
Circulation Research|January 17, 2015
Macrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosisKevin M Patel, Alanna Strong, Junichiro Tohyama, et al.
Journal of Lipid Research|May 11, 1992
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosisD J Rader, R E Gregg, M S Meng, et al.
Coronary Artery Disease|March 17, 2004
Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemiaDonald B Hunninghake, Evan A Stein, Harold E Bays, et al.
Pharmacogenetics and Genomics|June 20, 2017
Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapySony Tuteja, Lu Wang, Richard L Dunbar, et al.
Lipids|April 30, 2014
Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid speciesYanbo Yang, Takashi Kuwano, William R Lagor, et al.
European Heart Journal|January 14, 2016
Safety and efficacy of LY3015014, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 (PCSK9): a randomized, placebo-controlled Phase 2 studyJohn J P Kastelein, Steven E Nissen, Daniel J Rader, et al.
Pageof 103